| NCT ID | NCT06878391 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chuncheon Sacred Heart Hospital |
| Condition | Rotator Cuff Tear |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-03-24 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-03-24 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a prospective, randomized, double-blind trial comparing patients who underwent arthroscopic rotator cuff repair and received an interscalene brachial plexus block (9 ml of 0.75% ropivacaine, 3 ml for each trunk) combined with suprascapular nerve block and axillary nerve block (each with 10 ml of 0.75% ropivacaine) versus those who received an interscalene brachial plexus block (9 ml of 0.75% ropivacaine, 3 ml for each trunk) combined with placebo suprascapular and axillary nerve blocks (each with 10 ml of 0.9% saline). The study will compare subjective pain scores (VAS score) and patient satisfaction preoperatively and at 1, 3, 6, 12, 18, 24, 36, and 48 hours postoperatively. Additionally, 5 ml of venous blood will be collected preoperatively and at 1, 6, 12, 24, and 48 hours postoperatively to analyze and compare serum levels of cortisol, IL-6, IL-8, IL-1β, substance P, serotonin, β-endorphin, and norepinephrine.
Eligibility Criteria
Inclusion Criteria: * a definite rotator cuff tear that needed repair seen on preoperative magnetic resonancce imaging (MRI) * acceptance of arthroscopic surgery including rotator cuff repair * age same as or more than 20 years * acceptance of preemptive regional block and PCA, and blood testing Exclusion Criteria: * did not undergo arthroscopic rotator cuff repair * stopped PCA before 48 hours postoperatively because of associated side effects * a history of previous ipsilateral shoulder operation or fracture * a concomitant neurologic disorder around the shoulder * a failure of blood sampling including hemolysis, etc.
Contact & Investigator
Jung-Taek Hwang, MD, PhD
PRINCIPAL INVESTIGATOR
Hallym University Medical Center
Frequently Asked Questions
Who can join the NCT06878391 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Rotator Cuff Tear. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06878391 currently recruiting?
Yes, NCT06878391 is actively recruiting participants. Contact the research team at drakehjt@hanmail.net for enrollment information.
Where is the NCT06878391 trial being conducted?
This trial is being conducted at Chuncheon, South Korea, Chuncheon, South Korea.
Who is sponsoring the NCT06878391 clinical trial?
NCT06878391 is sponsored by Chuncheon Sacred Heart Hospital. The principal investigator is Jung-Taek Hwang, MD, PhD at Hallym University Medical Center. The trial plans to enroll 100 participants.